nadp has been researched along with Parkinson Disease in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Mamelak, M | 1 |
| Ganesan, S; Heijjer, CN; Hwang, IY; Karlsson, MCI; Kehrl, JH; Nabar, NR; Shi, CS | 1 |
| Chung, J; Kang, KS; Kim, EY; Kim, H; Kim, MJ; Koh, H; Lee, Y; Min, B; Park, HT; Son, JH; Yang, J; Yoon, W | 1 |
| Hemmati-Dinarvand, M; Mota, A; Samadi, N; Taher-Aghdam, AA; Zununi Vahed, S | 1 |
| Hemmati-Dinarvand, M; Mota, A; Samadi, N; Taheraghdam, A; Zununi Vahed, S | 1 |
| Chen, Z; Han, F; Han, R; Li, M; Qin, ZH; Sheng, R; Wang, Y; Wu, J; Zhou, Y | 1 |
| Choi, JG; Du, XF; Eo, H; Hong, SP; Huh, E; Jeong, JS; Kim Pak, Y; Kwon, Y; Oh, MS; Sim, Y; Soh, HY | 1 |
| Allen, GF; Bandopadhyay, R; Duberley, KE; Dunn, L; Hargreaves, IP; Heales, SJ; Holton, JL; Lees, A; Li, A; Ling, H; Mamais, A; Pope, S | 1 |
| Brailoiu, E; Brailoiu, GC; Eden, ER; Futter, CE; Hockey, LN; Kilpatrick, BS; Lin-Moshier, Y; Marchant, JS; Patel, S; Schapira, AH | 1 |
| Churchill, GC; Gómez-Suaga, P; Hilfiker, S; Patel, S | 1 |
| Dunbar, GL; Haik, KL; Hargrove, C; Mazei-Robison, M; Patton, J; Sandstrom, MI; Shear, DA | 1 |
| Birkmayer, GJ; Birkmayer, W | 1 |
| Edelstein, LM | 1 |
2 review(s) available for nadp and Parkinson Disease
| Article | Year |
|---|---|
A link between LRRK2, autophagy and NAADP-mediated endolysosomal calcium signalling.
Topics: Autophagy; Calcium Signaling; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Lysosomes; Mutation; NADP; Parkinson Disease; Protein Serine-Threonine Kinases | 2012 |
Melanin: a unique biopolymer.
Topics: Adenosine Triphosphate; Animals; Binding Sites; Catecholamines; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; Jaundice, Chronic Idiopathic; Leukocytes; Liver; Melanins; Melanocytes; Melanoma; Mice; NADP; Oxidation-Reduction; Parkinson Disease; Radiation Effects; Spectrophotometry; Ultraviolet Rays | 1971 |
11 other study(ies) available for nadp and Parkinson Disease
| Article | Year |
|---|---|
The Treatment of Parkinson's Disease with Sodium Oxybate.
Topics: Calcium; Dopaminergic Neurons; Glutamates; Humans; NADP; Parkinson Disease; Sodium Oxybate; Synucleins | 2023 |
LRRK2 is required for CD38-mediated NAADP-Ca
Topics: Adenosine Diphosphate Ribose; Antibodies, Monoclonal; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Calcium; Humans; Leucine; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Lipopolysaccharides; Lysosomes; NADP; Parkinson Disease; Transcription Factors | 2022 |
Isocitrate protects DJ-1 null dopaminergic cells from oxidative stress through NADP+-dependent isocitrate dehydrogenase (IDH).
Topics: Animals; Disease Models, Animal; Dopaminergic Neurons; Drosophila melanogaster; Drosophila Proteins; Gene Expression Regulation; High-Throughput Nucleotide Sequencing; Humans; Isocitrate Dehydrogenase; Isocitrates; Mitochondria; NADP; Nerve Degeneration; Nerve Tissue Proteins; NF-E2 Transcription Factor; Oxidative Stress; Parkinson Disease | 2017 |
Dysregulation of serum NADPH oxidase1 and ferritin levels provides insights into diagnosis of Parkinson's disease.
Topics: Aged; Case-Control Studies; Female; Ferritins; Humans; Iran; Male; Middle Aged; NADP; NADPH Oxidases; Oxidative Stress; Parkinson Disease; ROC Curve; Selenium; Sensitivity and Specificity; Uric Acid | 2017 |
In response to a letter to Editor by Vivek Kumar Garg., et al. on our paper: "Dysregulation of serum NADPH oxidase1 and ferritin levels provides insights into diagnosis of Parkinson's disease". Hemmati-Dinarvand, M., et al. 2017; 50 (18):1087-1092.
Topics: Ferritins; Humans; NADP; Parkinson Disease; Serum | 2018 |
Reduced Nicotinamide Adenine Dinucleotide Phosphate Inhibits MPTP-Induced Neuroinflammation and Neurotoxicity.
Topics: Animals; Dopaminergic Neurons; Encephalitis; Inflammasomes; Inflammation Mediators; Male; Mice, Inbred C57BL; Microglia; MPTP Poisoning; NADP; Neuroprotective Agents; Oxidative Stress; Parkinson Disease | 2018 |
Protective effects of DA-9805 on dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity in the models of Parkinson's disease.
Topics: Animals; Antioxidants; Apoptosis; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Male; Mice; Mice, Inbred ICR; NADP; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidopamine; Parkinson Disease; PC12 Cells; Plant Extracts; Plant Preparations; Rats | 2019 |
Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease.
Topics: Aged; Aged, 80 and over; Animals; Antioxidants; Cell Death; Cerebellum; Dopaminergic Neurons; Female; Glucose; Glucosephosphate Dehydrogenase; Humans; Male; NADP; Neurons; Parkinson Disease; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Putamen | 2014 |
Dysregulation of lysosomal morphology by pathogenic LRRK2 is corrected by TPC2 inhibition.
Topics: Calcium; Calcium Channels; Calcium Signaling; Fibroblasts; HEK293 Cells; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Lysosomes; NADP; Parkinson Disease; Primary Cell Culture; Protein Serine-Threonine Kinases | 2015 |
7-nitroindazole attenuates 6-hydroxydopamine-induced spatial learning deficits and dopamine neuron loss in a presymptomatic animal model of Parkinson's disease.
Topics: Analysis of Variance; Animals; Behavior, Animal; Disease Models, Animal; Dopamine; Indazoles; Learning Disabilities; Male; Maze Learning; NADP; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Spatial Behavior; Substantia Nigra | 2008 |
Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH).
Topics: Adult; Aged; Aged, 80 and over; Drug Evaluation; Humans; Levodopa; Male; Middle Aged; NAD; NADP; Parkinson Disease | 1989 |